Hepatitis C: Grading and Staging by MR - Tabular View

Tracking Information
First Received Date ^ICMJE	April 24, 2003
Last Updated Date	November 29, 2007
Start Date ^ICMJE	April 2003
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	Complete list of historical versions of study NCT00059397 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	Hepatitis C: Grading and Staging by MR
Official Title ^ICMJE	Hepatitis C: Grading and Staging by MR
Brief Summary	To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
Detailed Description
Study Phase
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Prospective
Condition ^ICMJE	Hepatitis
Intervention ^ICMJE
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Estimated Enrollment ^ICMJE	80
Completion Date
Primary Completion Date
Eligibility Criteria ^ICMJE	Referral only
Gender	Both
Ages	18 Years to 75 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States

Administrative Information
NCT ID ^ICMJE	NCT00059397
Responsible Party
Study ID Numbers ^ICMJE	HCGSMR (DK62765)
Study Sponsor ^ICMJE	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Verification Date	November 2007
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP